Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus

Microbes and Infection

Volumn 12, Issue 5, 2010, Pages 415-419

  Mader, Diana ^a   Rabiet, Marie Joséphe ^b,c,d   Boulay, Francois ^b,c,d   Peschel, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CEA GRENOBLE   (France)

^c CNRS   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Actinonin; Chemotaxis; Formyl peptide receptor; IL 8; Inflammation; Methionyl tRNA formyltransferase; Peptide deformylase; Staphylococcus aureus

Indexed keywords

ACTINONIN; BACTERIAL PROTEIN; CALCIUM ION; CD11B ANTIGEN; FORMYLPEPTIDE RECEPTOR; INTERLEUKIN 8; PEPTIDE DEFORMYLASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UPREGULATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 77950858310     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.01.014     Document Type: Article

References (21)

1. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 339 (1998) 520-532
2. Diep B.A., and Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 16 (2008) 361-369
3. Foster T.J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3 (2005) 948-958
4. Rooijakkers S.H., van Kessel K.P., and van Strijp J.A. Staphylococcal innate immune evasion. Trends Microbiol. 13 (2005) 596-601
5. Chavakis T., Preissner K.T., and Herrmann M. The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol. 28 (2007) 408-418
6. Jin T., Xu X., and Hereld D. Chemotaxis, chemokine receptors and human disease. Cytokines 44 (2008) 1-8
7. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A., and Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79 (2006) 247-256
8. Le Y., Murphy P.M., and Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 23 (2002) 541-548
9. Dürr M.C., Kristian S.A., Otto M., Matteoli G., Margolis P.S., Trias J., Van Kessel K.P., Van Strijp J.A., Bohn E., Landmann R., and Peschel A. Neutrophil chemotaxis by pathogen-associated molecular patterns - formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol. 8 (2006) 207-217
10. Rot A., Henderson L.E., Copeland T.D., and Leonard E.J. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7967-7971
11. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., DeLeo F.R., and Otto M. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13 (2007) 1510-1514
12. Queck S.Y., Khan B.A., Wang R., Bach T.H., Kretschmer D., Chen L., Kreiswirth B.N., Peschel A., Deleo F.R., and Otto M. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog. 5 (2009) e1000533
13. Gao J.L., Lee E.J., and Murphy P.M. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189 (1999) 657-662
14. de Haas C.J., Veldkamp K.E., Peschel A., Weerkamp F., van Wamel W.J., Heezius E.C., Poppelier M.J., Van Kessel K.P., and Van Strijp J.A. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199 (2004) 687-695
15. Margolis P.S., Hackbarth C.J., Young D.C., Wang W., Chen D., Yuan Z., White R., and Trias J. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob. Agents Chemother. 44 (2000) 1825-1831
16. Leeds J.A., and Dean C.R. Peptide deformylase as an antibacterial target: a critical assessment. Curr. Opin. Pharmacol. 6 (2006) 445-452
17. Fu H., Dahlgren C., and Bylund J. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy. Antimicrob. Agents Chemother. 47 (2003) 2545-2550
18. Johansson B., Wymann M.P., Holmgren-Peterson K., and Magnusson K.E. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist. J. Cell. Biol. 121 (1993) 1281-1289
19. Dahlgren C., Christophe T., Boulay F., Madianos P.N., Rabiet M.J., and Karlsson A. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-dMet activates neutrophils preferentially through the lipoxin A (4) receptor. Blood 95 (2000) 1810-1818
20. 2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276 (2001) 21585-21593
21. Somerville G.A., Cockayne A., Dürr M., Peschel A., Otto M., and Musser J.M. Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J. Bacteriol. 185 (2003) 6686-6694